-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QK3OduPnADKyMJHTvoufIWc8JRRYY84FFaFIbg1tUjOSEsoCu2nUSHs7QuC79QYT +rENMvypxDjVoGeODpdUWg== 0000932799-03-000165.txt : 20030903 0000932799-03-000165.hdr.sgml : 20030903 20030903172611 ACCESSION NUMBER: 0000932799-03-000165 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20030903 ITEM INFORMATION: Changes in registrant's certifying accountant FILED AS OF DATE: 20030903 FILER: COMPANY DATA: COMPANY CONFORMED NAME: EP MEDSYSTEMS INC CENTRAL INDEX KEY: 0001012394 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 223212190 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-28260 FILM NUMBER: 03879830 BUSINESS ADDRESS: STREET 1: 100 STIERLI COURT STREET 2: SUITE 107 CITY: MOUNT ARLINGTON STATE: NJ ZIP: 07856 BUSINESS PHONE: 9733982800 MAIL ADDRESS: STREET 1: 575 ROUTE 73 N BUILDING D CITY: WEST BERLIN STATE: NJ ZIP: 08091 8-K 1 epe8k.txt FORM 8K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 3, 2003 EP MedSystems, Inc. (Exact name of small business issuer as specified in its charter) New Jersey 0-28260 22-3212190 (State or other jurisdiction (Commission (IRS Employer of incorporation) File Number) Identification No.) 575 Route 73 N. Building D West Berlin, New Jersey 08091 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: (856) 753-8533 Not Applicable (Former name or former address, if changed since last report) Item 4. Changes in Registrant's Certifying Accountant On September 3, 2003, the Registrant engaged Grant Thornton LLP as its new independent accountants to audit the Registrant's financial statements for the year ended December 31, 2003. The Registrant has not consulted with Grant Thornton LLP during the two most recent fiscal years, or during the interim period through September 3, 2003, on any matter which was the subject of any disagreement, or on the application of accounting principles to a specified transaction, either completed or proposed, or the type of audit opinion that might be rendered on the Registrant's financial statements, relating to which either a written report was provided to the Registrant or oral advice was provided that Grant Thornton LLP concluded was an important factor considered by the Registrant in reaching a decision as to the accounting, auditing, or financial reporting issue. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. EP MEDSYSTEMS, INC. Registrant Date: September 3, 2003 By: /s/ Matthew C. Hill_____ Matthew C. Hill Chief Financial Officer -----END PRIVACY-ENHANCED MESSAGE-----